Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 1388

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 8
Chunk 1388
---
5) 
     1,901  
     - 
  
    All directors and officers as a group (ten persons) 
     929,451  
     22.78%

    Other 5% beneficial owners: 

    Armistice Capital LLC(6) 
     306,057  
     7.5%

    -
    Denotes the holder owns less than one percent of the outstanding common stock.

    ±
    The persons named above have full voting and investment power with respect to the shares indicated. Under the rules of the SEC, a person (or group of persons) is deemed to be a “beneficial owner” of a security if he or she, directly or indirectly, has or shares the power to vote or to direct the voting of such security, or the power to dispose of or to direct the disposition of such security. Accordingly, more than one person may be deemed to be a beneficial owner of the same security.

    (1)
    Consists of (i) 135,650 shares of common stock held of record by Dr. Anatoly Dritschilo, (ii) warrants to purchase 100,382 shares of common stock, exercisable at $1.40 per share, (iii) 138,051 shares of common stock and warrants to purchase 2,500 shares of commons stock, each held of record by Joy Dritschilo, his spouse, and (iv) 262,500 shares of common stock held by PAL Trust, a trust formed for the benefit of Dr. and Mrs. Dritschilo’s adult children and for which a third party serves as external trustee and two of their children serve as co-trustees. The above amounts do not include the potential conversion of a $250,000 convertible note, which may be paid in cash or subject to conversion. Dr. Dritschilo disclaims beneficial ownership over all securities held by Mrs. Dritschilo and PAL Trust.
  
    (2)
    Does not include 28,455 RSUs that remain subject to vesting.
  
    (3)
    Does not include 210,832 RSUs that remain subject to vesting.
  
    (4)
    Does not include 1,194 RSUs that remain subject to vesting.
  
    (5)
    Does not include 209,791 RSUs that remain subject to vesting.
  
    (6)
    Armistice Capital, LLC (“Armistice Capital